College of Psychiatric && Neurologic Pharmacists, The Mental Health Clinician, 9(1), p. 217-221, 2012
DOI: 10.9740/mhc.n99509
Full text: Unavailable
Bipolar Disorder (BD) is a common psychiatric illness that has a recurring course and 17% - 24% lifetime prevalence of suicide attempts. Difficulty in diagnosis and individual variation in response point to a great need for personalized medicine. Studies to date have focused largely on lithium and suggest the idea that different medication responses may reflect different disease mechanisms. An overview of current pharmacogenomic studies will be presented and needs and future directions discussed.